Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy in the Treatment of Oral Vascular Malformations

Small vascular anomalies are commonly present on the lips and other areas of the oral mucosa. These lesions are also known as venous lake lesions, and they can be treated in many ways with surgical and non-surgical methods. Laser is an arising technique for this type of procedure and its use has been growing in dental practices in the last years. The technique that uses the diode laser delivers the energy in a non-contact treatment, leading to the coagulation of the lesion in a minimally invasive manner, and for this reason, there is less chance of developing scar formation. In this report, a 56-year-old female patient had a vascular lesion on her lower lip measuring about 3.0 mm in diameter. The patient reported having it for more than 10 years. A first approach using a high-power diode laser had already been done but with no success. At this time, the diode laser was used under local anesthesia, with a flexible quartz fiber held 2 to 3 mm from the lesion, using the continuous wave mode set, 1.0 W of power for 10 seconds, with an interval of 30 seconds to prevent heat damage to the adjacent tissue. The laser was applied until the lesion appeared white and with evidence of shrinkage. In this case, two rounds of irradiation were done. After a 30-day follow-up, the lesion was repaired with no signs of scars on the lip. The diode laser is an effective technique for treating this type of lesion, with many advantages, such as providing coagulation, excellent healing, no postoperative complication, and no need for suturing. Besides all, it is also a low-cost procedure, small lesions usually require only one appointment, and this treatment is also better accepted by the patients.

Section: Discussionmentioning

confidence: 99%

Importance of the Right Protocol in Using a Diode Laser (980 nm) for Small Oral Vascular Malformation Treatment

Vidor¹,

Azevedo²,

Freitas³

2023

“…Fibrosis and contracture eventually cause the lesion to disappear [ 7 ]. Because of their safety and efficacy, sodium tetradecyl sulfate (STS), OK-432, monoethanolamine oleate, polidocanol, hypertonic glucose solution, ethanol, sodium morrhuate, bleomycin, and corticosteroids have been used in various oral diseases, including vascular malformation, pyogenic granuloma, mucocele, and ranula [ 7 , 13 , 14 ].…”

Section: Discussionmentioning

confidence: 99%

Lymphangioma of the Oral and Maxillofacial Region: A Report of Three Cases

Haidry¹,

Shivhare²,

Vaidyanathan³

et al. 2022

Self Cite

Lymphangiomas, or lymphatic malformations (LM), are benign malformations of the lymphatic system characterized by abnormal proliferation of lymphatic vessels. It was first described by Virchow in 1854. They occur rarely in the oral cavity and involve the tongue dorsum more often. Though complete surgical excision is the gold standard and most desirable management, certain limitations restrict this approach. Laser therapy, cryotherapy, electrocautery, sclerotherapy, and intralesional injections of steroids and Bevacizumab are other treatment options in such cases. Here, we present three cases of diverse forms of lymphatic malformations treated with two different modalities of treatment.

“…However, there is ongoing debate regarding the optimal choice of sclerosing agent and the need for additional interventions alongside sclerotherapy. Several studies have compared the outcomes of interventions with and without sclerotherapy, aiming to determine the efficacy and safety of this treatment modality [ 11 ]. In this review, we examined the results of these studies and explored the benefits and limitations of sclerotherapy compared to other interventions.…”

Section: Reviewmentioning

confidence: 99%

Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta-Analysis

Dewi,

Arimuko,

Norawati

et al. 2023

Chronic venous insufficiency is a medical condition that impacts the venous system in the lower limbs. The primary characteristic of this condition is the continual elevation of pressure within the leg veins due to walking, which leads to a range of associated issues, such as discomfort, swelling, alterations in the skin, and the development of ulcers. Sclerotherapy has emerged as a potentially effective treatment for chronic venous insufficiency, involving the injection of a sclerosing agent into the affected veins. This study aimed to evaluate the effectiveness of sclerotherapy in treating chronic venous insufficiency grades 1-6 in the lower limb through a systematic review and meta-analysis. The method for conducting this research is by searching articles with relevant keywords carried out through electronic databases, such as Cochrane Library, Pubmed, and Google Scholar. The researchers conducted a comprehensive search and included randomized controlled trials and clinical trials that assessed outcomes, such as patient satisfaction, clinical resolution, quality of life (QoL), and closure rates. Statistical methods were used to analyze the data. The results of the meta-analysis from 9.670 total samples showed that sclerotherapy is the most effective therapy for reducing clinical severity in lower limb venous insufficiency patients (pooled MD = -0.85, 95% CI (-1.41, -0.29), p < 0.00001, I 2 = 99%). Sclerotherapy is the most effective therapy for increasing QoL if we use Venous Insufficiency Epidemiology and Economic Study-Quality of Life (VEINES-QOL) as a tool for measuring the QoL (VEINES-QOL scale types; pooled MD = 10.34, 95% CI (8.78, 11.90), p < 0.00001, I 2 = 0%). Additionally, sclerotherapy is a more effective therapy for increasing QoL compared to placebo (pooled MD = -1.64, 95% CI (-2.60, -0.67), p = 0.002, I 2 = 90%), deferred ablation (pooled MD = -0.22, 95% CI (-0.40, -0.03), p = 0.02), and ligation therapy (pooled MD = -1.29, 95% CI (-1.62, -0.97), p = 0.00001). It is also the most effective therapy for increasing the closure rate for 12-month duration outcome measures (pooled RR = 0.72, 95% CI (0.55, 0.94), p = 0.001, I 2 = 91%). However, high heterogeneity was observed in the meta-analysis results, indicating the need for further research to address this variability. This study contributes to the existing body of knowledge on the treatment options for chronic venous insufficiency and highlights the potential of sclerotherapy as an effective treatment modality.